Receptor Interacting Ser/Thr-Protein Kinase ...

Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
DOI :
10.1021/acs.jmedchem.3c00593
PMID :
37857324
Permalink :
http://hdl.handle.net/20.500.12210/100529
Title :
Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.
Author(s) :
Rivoal, Morgane [Auteur]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Dubuquoy, Laurent [Auteur] orcid refId
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Millet, Régis [Auteur] refId
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Chavain, Natascha [Auteur] refId
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Journal title :
Journal of Medicinal Chemistry
Abbreviated title :
J Med Chem
Publication date :
2023-10-21
ISSN :
1520-4804
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Receptor interacting serine/threonine protein kinase 2 (RIPK2) is a downstream signaling molecule essential for the activation of several innate immune receptors, including the NOD-like receptors (NOD1 and NOD2). Recognition ...
Show more >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Collections :
Submission date :
2024-01-11T22:09:01Z
2024-03-08T09:37:25Z
Version history
VersionLinkModification date
220.500.12210/100529*2024-03-08T09:35:45Z
120.500.12210/100529.12024-01-11T22:09:01Z

*Selected version